Atreca Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11203
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atreca Inc (Atreca) is a biotechnology company that develops and develops novel therapies based on the human immune response. The company develops proprietary immune repertoire capture technology that act as an engine for the discovery and development of antibody based therapeutics, diagnostics, vaccines and research reagents. Its technology has partnerships with pharmaceutical companies, academic institutions, non-profit foundations and governmental entities. Its pipeline products are intended for the treatment of breast tumor, lung tumor, colon tumor and other solid tumors. Atreca is headquartered in Redwood City, California, the US.

Atreca Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9
Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Atreca Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Atreca Raises USD125 Million in Series C Venture Financing 12
Atreca Raises USD35 Million in Series B Financing 14
Atreca Raises USD56 Million in Series A Financing 15
Atreca Raises USD57.26 Million in Venture Financing 16
Atreca Raises USD0.7 Million in Venture Financing 17
Atreca Raises USD0.05 Million in Venture Financing 18
Atreca Raises USD3 Million in Venture Financing 19
Atreca Raises Funds through Venture Financing 20
Atreca Raises USD0.4 Million in Venture Financing 21
Partnerships 22
Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22
Atreca Enters into Agreement with Genome Institute of Singapore 23
Atreca Enters into Research Agreement with Janssen Biotech 24
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25
Licensing Agreements 26
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26
Atreca Inc – Key Competitors 27
Atreca Inc – Key Employees 28
Atreca Inc – Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
Corporate Communications 30
Apr 19, 2018: Atreca Names John A. Orwin As President and CEO 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Atreca Inc, Pharmaceuticals & Healthcare, Key Facts 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9
Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Atreca Raises USD125 Million in Series C Venture Financing 12
Atreca Raises USD35 Million in Series B Financing 14
Atreca Raises USD56 Million in Series A Financing 15
Atreca Raises USD57.26 Million in Venture Financing 16
Atreca Raises USD0.7 Million in Venture Financing 17
Atreca Raises USD0.05 Million in Venture Financing 18
Atreca Raises USD3 Million in Venture Financing 19
Atreca Raises Funds through Venture Financing 20
Atreca Raises USD0.4 Million in Venture Financing 21
Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22
Atreca Enters into Agreement with Genome Institute of Singapore 23
Atreca Enters into Research Agreement with Janssen Biotech 24
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26
Atreca Inc, Key Competitors 27
Atreca Inc, Key Employees 28

List of Figures
Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Atreca Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PolyNovo Ltd (PNV):企業の財務・戦略的SWOT分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, designs, develops and manufactures dermal regeneration solutions for various medical applications. The company offers NovoSorb BTM (Biodegradable Temporising Matrix), a synthetic, biodegradable and biocompatible device that facilitates the growt …
  • Ezion Holdings Limited:企業のM&A・事業提携・投資動向
    Ezion Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ezion Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Covea Mutual Insurance Group Company:企業の戦略・SWOT・財務情報
    Covea Mutual Insurance Group Company - Strategy, SWOT and Corporate Finance Report Summary Covea Mutual Insurance Group Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • SmarTone Telecommunications Holdings Ltd (315):企業の財務・戦略的SWOT分析
    SmarTone Telecommunications Holdings Ltd (315) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Westlake Chemical Corp (WLK):企業の財務・戦略的SWOT分析
    Summary Westlake Chemical Corp (Westlake Chemical) is a chemical company that manufactures and distributes petrochemicals, plastics and building products. The company offers products such as olefins, vinyls, styrene, polyethylene, epolene polymers, and others. It manufactures two primary petrochemic …
  • Stolt-Nielsen Ltd (SNI)-石油・ガス分野:企業M&A・提携分析
    Summary Stolt-Nielsen Ltd (Stolt-Nielsen) formerly Stolt-Nielsen S.A., is an integrated global transportation company, which provides bulk-liquid transportation, storage and distribution services. The company services include transportation of liquefied petroleum gas (LPG), terminal storage and dist …
  • National Beverage Corp. (FIZZ):企業の財務・戦略的SWOT分析
    National Beverage Corp. (FIZZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ringkjoebing Landbobank A/S:企業の戦略・SWOT・財務情報
    Ringkjoebing Landbobank A/S - Strategy, SWOT and Corporate Finance Report Summary Ringkjoebing Landbobank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nippon Suisan Kaisha, Ltd.:企業の戦略・SWOT・財務情報
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BKW AG (BKW):電力:M&Aディール及び事業提携情報
    Summary BKW AG (BKW) is an energy and infrastructure company, which plans, builds and operates infrastructure to produce and supply energy. It generates electricity from varied fuel sources such as hydro, nuclear, fossil, and renewable sources primarily, wind and small hydro, besides solar and bioma …
  • China Animal Husbandry Industry Co Ltd (600195):企業の財務・戦略的SWOT分析
    China Animal Husbandry Industry Co Ltd (600195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • McAlister’s Corporation:企業の戦略・SWOT・財務情報
    McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report Summary McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mitsubishi Heavy Industries Ltd (7011):企業の財務・戦略的SWOT分析
    Mitsubishi Heavy Industries Ltd (7011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Dominion Energy Inc (D):電力:M&Aディール及び事業提携情報
    Summary Dominion Energy, Inc. (Dominion), formerly Dominion Resources, Inc., is a producer and transporter of energy. It carries out the generation, transmission and distribution of electricity; transmission, distribution, storage and processing of gas; and LNG import and storage activities. The com …
  • Brunel International NV (BRNL):企業の財務・戦略的SWOT分析
    Brunel International NV (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Deciphera Pharmaceuticals LLC (DCPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Deciphera Pharmaceuticals LLC (Deciphera Pharmaceuticals) is a research and development company that develops, designs, and commercializes kinase inhibiting drugs. The company provides clinical pipeline of kinase inhibitors such as tumor-targeted therapies and immuno-targeted therapies. It u …
  • Petrosibir AB (SHEL B):企業の財務・戦略的SWOT分析
    Summary Petrosibir AB (Petrosibir), formerly Shelton Petroleum AB is an oil and gas company. The company offers exploration and development of oil and gas assets and the resource-rich basins in Russia and Ukraine. It holds Ayazovskoye production license and Rustamovskoye exploration license that cov …
  • Ping An Insurance (Group) Company of China, Ltd.:企業のM&A・事業提携・投資動向
    Ping An Insurance (Group) Company of China, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ping An Insurance (Group) Company of China, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • IHI Corporation (7013)-エネルギー分野:企業M&A・提携分析
    Summary IHI Corporation (IHI) is a heavy machinery engineering group. It provides technology oriented products and services to customers in the public, private and industrial sectors across the world. The group designs and manufactures a diverse range of products including ships and offshore facilit …
  • MRC Global Inc (MRC)-石油・ガス分野:企業M&A・提携分析
    Summary MRC Global Inc (MRC) is a provider of pipe, valves and fittings. Its product portfolio include carbon steel pipe, carbon steel fittings and flanges, valve automation, stainless and alloy pipe, stainless and alloy fittings and flanges, industrial products, specialty products, oilfield product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆